Boehringer Ingelheim Signs Four-year Agreement with Ingenuity Systems
Boehringer Ingelheim has reached a multi-year global access agreement with Ingenuity Systems to use its latest release of Pathway Analysis software IPA 6, which according to a statement includes new biological and chemical content, in addition to Path Designer software tools.
GenomeWeb Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.
Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.
Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.
In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.
This webinar will provide an overview of recent advances in single-cell RNA sequencing from the perspectives of three research organizations.
This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.